P3 Health Partners Inc. 8K
0001832511-26-000032
View on SEC EDGARP3 Health Partners Inc. announced improved second quarter 2026 profitability and raised full-year 2026 adjusted EBITDA and medical margin guidance while hosting an earnings call to discuss results.
P3 Health Partners Inc. reported strong financial results for the quarter ended June 30, 2026, highlighted by a return to profitability with $15.7 million in net income versus a prior-year loss, $54.4 million in adjusted EBITDA versus a prior-year adjusted EBITDA loss, 9% year-over-year revenue growth to $386 million, and substantial improvement in medical margin driven in part by favorable payer settlements and prior-year development; while at-risk membership declined 10% due to intentional network and payer rationalization, management raised full-year 2026 guidance for revenue, medical margin, and adjusted EBITDA, and announced a same-day earnings conference call and webcast to discuss results.
Filing Facts
- CIK
- 1832511
- Ticker
- -
- Form
- 8K
- Source Type
- sec
- Accession
- 0001832511-26-000032
- Alert Tier
- 6